Assaf Ahmed, Kotb Ahmed
Ophthalmology Department, Ain-Shams University, Cairo, Egypt.
Int Ophthalmol. 2015 Jun;35(3):411-9. doi: 10.1007/s10792-014-9963-3. Epub 2014 Jul 1.
To assess the efficacy and stability of simultaneous topography-guided photorefractive keratectomy (PRK) and crosslinking (Athens protocol) followed by phakic intraocular lens (IOL) implantation for managing keratoconus. Ain-Shams University, Cairo, Egypt. Prospective non-randomized study. All patients underwent topography-guided PRK followed immediately by collagen crosslinking (Athens protocol), 2-4 months later, eyes were implanted with either an iris claw or an angle-supported phakic IOL. Statistical analysis was performed with SigmaPlot software version 11.0 (Systat Software, Inc.). This study evaluated 22 eyes of 14 patients. Follow-up interval was at least 6 months. A Veriflex phakic IOL was implanted in 14 eyes (63.6 %), and a Cachet phakic IOL was implanted in 8 eyes (36.4 %). The mean preoperative keratometric reading (45.57 ± 1.51 D) was significantly reduced at 3 months and at 6 months after treatment (43.82 ± 1.98 D, P < 0.001). The mean spherical equivalent was significantly reduced from -9.08 ± 2.5 to -0.69 ± 0.67 D, P = <0.001. The mean UCVA improved from 1.24 ± 0.49 to 0.37 ± 0.08 logMAR. The mean corrected distance visual acuity (CDVA; logMAR) improved from 0.69 ± 0.3 preoperatively to 0.35 ± 0.01 postoperatively (P = <0.001). At last follow-up, all eyes could achieve CDVA of 0.3 or better. The difference between pre- and postoperative endothelial cell counts was not statistically significant. Combining phakic IOLs and the Athens protocol improved and stabilized visual performance in patients with keratoconus. These results justify a future, large-scale study with a longer follow-up.
评估同步角膜地形图引导的准分子激光原位角膜磨镶术(PRK)和交联术(雅典方案),随后植入有晶状体眼人工晶状体(IOL)治疗圆锥角膜的疗效和稳定性。埃及开罗艾因夏姆斯大学。前瞻性非随机研究。所有患者均接受角膜地形图引导的PRK,随后立即进行胶原交联术(雅典方案),2至4个月后,为患眼植入虹膜爪型或房角支撑型有晶状体眼IOL。使用SigmaPlot软件11.0版(Systat软件公司)进行统计分析。本研究评估了14例患者的22只眼。随访时间至少为6个月。14只眼(63.6%)植入了Veriflex有晶状体眼IOL,8只眼(36.4%)植入了Cachet有晶状体眼IOL。术前平均角膜曲率读数(45.57±1.51 D)在治疗后3个月和6个月时显著降低(43.82±1.98 D,P<0.001)。平均球镜等效度从-9.08±2.5显著降低至-0.69±0.67 D,P<0.001。平均未矫正视力(UCVA)从1.24±0.49提高至0.37±0.08 logMAR。平均矫正远视力(CDVA;logMAR)从术前的0.69±0.3提高至术后的0.35±0.01(P<0.001)。在最后一次随访时,所有患眼的CDVA均可达到0.3或更好。术前和术后内皮细胞计数的差异无统计学意义。联合有晶状体眼IOL和雅典方案可改善并稳定圆锥角膜患者的视觉性能。这些结果为未来开展一项随访时间更长的大规模研究提供了依据。